# Cyclophosphamide in Lupus Nephritis

> **NCT00441220** · — · UNKNOWN · sponsor: **University of Auckland, New Zealand** · enrollment: 60 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00441220
- **Lead sponsor:** University of Auckland, New Zealand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2010-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-03-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441220, "Cyclophosphamide in Lupus Nephritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00441220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*